ACHE and Alzheimer disease: Scopolamine (a nonselective muscarinic blocker) has been widely used to establish an AD‐like model since it can induce cognitive and memory deficits by promoting acetylcholinesterase (AChE) and upregulating brain iron (Wang, Zhong, Gao, & Li, 2017).